Haemonetics (HAE) Operating Expenses (2009 - 2026)

Haemonetics' Operating Expenses history runs 18 years deep, the most recent figure standing at $221.2 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 81.77% year-over-year to $221.2 million in Q1 2026; TTM through Mar 2026 was $630.9 million, a 19.67% increase from a year earlier, with the FY2026 full-year figure at $630.9 million, up 19.67% from the prior year.
• Operating Expenses climbed to $221.2 million in Q1 2026 per HAE's latest filing, from $135.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $221.2 million in Q1 2026 and bottomed at $102.9 million in Q1 2022.
• The 5-year median for Operating Expenses is $133.2 million (2023), against an average of $131.3 million.
• Across the five-year window, Operating Expenses dropped 16.61% in 2025 and soared 81.77% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $115.4 million in 2022, then rose by 14.26% to $131.9 million in 2023, then increased by 1.99% to $134.5 million in 2024, then gained by 0.35% to $135.0 million in 2025, then surged by 63.89% to $221.2 million in 2026.
• Per Business Quant, the three latest HAE Operating Expenses figures stand at $221.2 million (Q1 2026), $135.0 million (Q4 2025), and $136.3 million (Q3 2025).